{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05008588",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CT/STROKE/PSI/2021"
      },
      "Organization": {
        "OrgFullName": "PT. Prodia Stem Cell Indonesia",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Sub-Acute Stroke Infarct",
      "OfficialTitle": "Safety and Efficacy of Combined Conditioned Medium With Umbilical Cord Mesenchymal Stem Cells as A Novel Strategy for Sub-Acute Stroke Infarct"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Not yet recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2021",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 1, 2021",
      "StudyFirstSubmitQCDate": "August 9, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 17, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "August 9, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 17, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "PT. Prodia Stem Cell Indonesia",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study was to determine the effectiveness of a combination of intranasal conditioned medium (CM) with intraparenchymal umbilical cord mesenchymal stem cells (UC-MSCs) transplantation in sub-acute stroke patients to induce neurogenesis. This study has 3 arms namely CM and UC-MSCs treatment, UC-MSCs treatment only, and control. The investigator hypothesized that group of CM and UC-MSCs combination is the optimal treatment to induce neurogenesis in stroke patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Ischemic Stroke"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Ischemic stroke",
          "Mesenchymal Stem Cells",
          "Conditioned Medium",
          "Secretome"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Factorial Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "15",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intranasal of 160 μl of conditioned medium",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Conditioned Medium",
                "Biological: Umbilical Cord Mesenchymal Stem Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Umbilical cord mesenchymal stem cells treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intra-parenchymal transplantation of 1-2x10^6 UC-MSCs",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Umbilical Cord Mesenchymal Stem Cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Standard treatment (control)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Neurologic and Neutrophic Drugs",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Neurologic and Neutrophic Drugs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Conditioned Medium",
            "InterventionDescription": "Intranasal of 160 μl of conditioned medium",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Secretome"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Umbilical Cord Mesenchymal Stem Cells",
            "InterventionDescription": "Intra-parenchymal transplantation of 1-2x10^6 UC-MSCs",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Conditioned medium combined with Umbilical cord mesenchymal stem cells treatment",
                "Umbilical cord mesenchymal stem cells treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Mesenchymal stromal cells"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "Neurologic and Neutrophic Drugs",
            "InterventionDescription": "Such as clopidogrel, piracetam, citicoline",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Standard treatment (control)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Change from baseline Brain-Derived Neutrophic Factor at one month, 3 months and 6 months after transplantation",
            "PrimaryOutcomeDescription": "Venous blood collection",
            "PrimaryOutcomeTimeFrame": "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment"
          },
          {
            "PrimaryOutcomeMeasure": "Change from baseline Vascular endothelial growth factor at one month, 3 months and 6 months after transplantation",
            "PrimaryOutcomeDescription": "Venous blood collection",
            "PrimaryOutcomeTimeFrame": "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment"
          },
          {
            "PrimaryOutcomeMeasure": "Change baseline Magnetic Resonance Imaging at 6 month after transplantation",
            "PrimaryOutcomeDescription": "To observe the brain development (neurogenesis)",
            "PrimaryOutcomeTimeFrame": "Before treatment, 6 month after transplantation"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "The National Institute of Health Stroke Scale (NIHSS) Scoring",
            "SecondaryOutcomeDescription": "The NIH Stroke Scale (NIHSS) is a 15-item scale that is a well-validated and prognostically important measure of stroke-related neurologic deficits in research and clinical care",
            "SecondaryOutcomeTimeFrame": "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment"
          },
          {
            "SecondaryOutcomeMeasure": "modified Rankin Scale (mRS)",
            "SecondaryOutcomeDescription": "The Modified Rankin Scale (mRS) is used to measure the degree of disability in patients who have had a stroke",
            "SecondaryOutcomeTimeFrame": "Before treatment, one month after treatment, 3 months after treatment, and 6 month after treatment"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female aged 60-80 years diagnosed with ischemic stroke acute or subacute phase\nThe patient has had a CT scan/MRI of the brain to assess ischemic territory\nThe patient must have an NIH Stroke score of 8-20\nThe patient or legal assistant has obtained detailed informed consent regarding the study protocol and agreeing to participate in the study\nPatients with The Glasgow Coma Scale (GCS) score > 8\nPatients with Pt-APTT values within normal limits\n\nExclusion Criteria:\n\nPatients with recurrent stroke in the 6 months preceding the episode current stroke\nCT or MRI images show midline shift and bleeding transformation\nParticipate in similar studies using CM and/or UC-MSC\nPatients who are immunocompromised and/or who are receiving therapy immunosuppressive\nPatients who cannot have a CT or MRI examination due to their condition\nPatients with impaired renal and hepatic function after the onset of ischemic stroke: Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) > 5x the upper limit of normal values and a significant increase in urea-creatinine values\nPatients with a history of malignant tumors or other severe neurologic conditions.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "60 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Gatot Soebroto Hospital",
            "LocationCity": "Jakarta Pusat",
            "LocationState": "DKI Jakarta",
            "LocationZip": "10410",
            "LocationCountry": "Indonesia"
          },
          {
            "LocationFacility": "PT Prodia StemCell Indonesia",
            "LocationCity": "Jakarta",
            "LocationCountry": "Indonesia"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000020521",
            "ConditionMeshTerm": "Stroke"
          },
          {
            "ConditionMeshId": "D000083242",
            "ConditionMeshTerm": "Ischemic Stroke"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000002561",
            "ConditionAncestorTerm": "Cerebrovascular Disorders"
          },
          {
            "ConditionAncestorId": "D000001927",
            "ConditionAncestorTerm": "Brain Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M21459",
            "ConditionBrowseLeafName": "Stroke",
            "ConditionBrowseLeafAsFound": "Stroke",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M2401",
            "ConditionBrowseLeafName": "Ischemic Stroke",
            "ConditionBrowseLeafAsFound": "Ischemic Stroke",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9434",
            "ConditionBrowseLeafName": "Infarction",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4962",
            "ConditionBrowseLeafName": "Cerebrovascular Disorders",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4356",
            "ConditionBrowseLeafName": "Brain Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M5923",
            "InterventionBrowseLeafName": "Cytidine Diphosphate Choline",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M1669",
            "InterventionBrowseLeafName": "Clopidogrel",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M12932",
            "InterventionBrowseLeafName": "Piracetam",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "NootAg",
            "InterventionBrowseBranchName": "Nootropic Agents"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "PlAggInh",
            "InterventionBrowseBranchName": "Platelet Aggregation Inhibitors"
          },
          {
            "InterventionBrowseBranchAbbrev": "NeuroAg",
            "InterventionBrowseBranchName": "Neuroprotective Agents"
          }
        ]
      }
    }
  }
}